Stroke Feature Archive
For more details about differences in stroke risk, prevention, and treatment in women, Neurology Advisor spoke with Elisabeth B. Marsh, MD, from Johns Hopkins School of Medicine and Kristy Yuan, MD, from the University of Pennsylvania.
Brief periods of oxygen deprivation to the brain have been shown to provide neuroprotective effects that reduce stroke infarct size and improve recovery times.
Despite disappointing results, tenecteplase's story in stroke treatment might not be over.
Neurologists need to engage their emergency medicine colleagues to identify protocols and pathways for when to trigger appropriate neurological consultation or initiate acute stroke therapies.
Recent research found benefits in outcome outweighed any increase in hemorrhagic complications in patients with large infarcts.
Although the study did not demonstrate efficacy of glyburide, differences were seen in the amount midline shift at 3-4 days.
Despite 3 large randomized trials and updated guidelines, the question of PFO closure remains a complex entity.
A joint medical and surgical approach may ensure the best outcome.
The idea of low-dose tPA will likely not be abandoned despite recent findings.
Ticagrelor may have an opportunity to shine in patients already on aspirin or clopidogrel.
Patients undergoing cardiac surgery should be evaluated for cardiovascular disease to assess stroke risk.
Interventional stroke treatment continues to rapidly evolve as health care providers implement new protocols to ensure more rapid, successful treatment.
New recommendations for the treatment of acute stroke put emergency physicians and neurology stroke specialists at odds.
Overlapping clinical characteristics between women with migraine and those using contraceptives may indicate an elevated risk of stroke.
The affect of stroke on young adults goes far beyond functional disabilities.
With no established guidelines, much of the decisions for management of hypertension during stroke are based on clinician experience.
The long-awaited results of the MR CLEAN trial are sure to affect the future of acute stroke treatment.
Robotics, stem cell therapy, and computer-controlled interfaces are promising, but cost may slow adoption.
If the UTHealth mobile stroke unit program can show that treating ischemic stroke within 60 minutes is feasible and cost effective, more may start rolling out nationally.
Neurology Advisor Articles
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Solriamfetol Associated With Improvement in Narcolepsy Types 1 and 2
- Novel Therapy May Improve Symptoms in Early Huntington Disease
- Interaction of Alcohol, Smoking on Multiple Sclerosis Severity
- Are Vaccines Associated With Multiple Sclerosis Relapse?
- The Symbiosis of Headache and Sleep
- Neurosurgery in Parkinson Disease: A Brief History and Look Forward
- Blood Pressure-Dementia Link May Be Affected by Population Characteristics
- The Consequences of Compensation in Autism
- Primary Periodic Paralysis: Advice for Clinicians & Future Directions
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Efficacy of Disease-Modifying Drugs for Multiple Sclerosis May Decrease With Age
- Wearable Sensors May Help Predict On, Off States in Parkinson Disease
- Pain, Psychiatric Comorbidities More Common in Chronic vs Episodic Migraine